{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T16:02:44Z","timestamp":1791734564986,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.pdpdt.2024.104432","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T23:11:20Z","timestamp":1733440280000},"page":"104432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Long-term outcome of photodynamic therapy with hexyl aminolevulinate, 5-aminolevulinic acid nanoemulsion and methyl aminolevulinate for low-risk Basal Cell Carcinomas"],"prefix":"10.1016","volume":"51","author":[{"given":"M.","family":"Salmivuori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gr\u00f6nroos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Tani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"R\u00e4s\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Snellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Neittaanm\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.pdpdt.2024.104432_bib0001","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1365-2133.2012.10830.x","article-title":"A systematic review of worldwide incidence of nonmelanoma skin cancer","volume":"166","author":"Lomas","year":"2012","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.1016\/j.pdpdt.2024.104432_bib0002","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/CEJ.0b013e328360150c","article-title":"Costs of illness for melanoma and nonmelanoma skin cancer in Denmark","volume":"22","author":"Bentzen","year":"2013","journal-title":"Eur. J. Cancer Prev Off. J. Eur. Cancer Prev. Organ. ECP"},{"issue":"12","key":"10.1016\/j.pdpdt.2024.104432_bib0003","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1468-3083.2010.03664.x","article-title":"A cost analysis of photodynamic therapy with methyl aminolevulinate and imiquimod compared with conventional surgery for the treatment of superficial basal cell carcinoma and Bowen's disease of the lower extremities","volume":"24","author":"Aguilar","year":"2010","journal-title":"J. Eur. Acad. Dermatol. Venereol. JEADV"},{"issue":"9","key":"10.1016\/j.pdpdt.2024.104432_bib0004","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s13555-023-00989-x","article-title":"Recommendations for cost-conscious treatment of basal cell carcinoma","volume":"13","author":"Patel","year":"2023","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.pdpdt.2024.104432_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113254","article-title":"European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma\u2014Update 2023","volume":"192","author":"Peris","year":"2023","journal-title":"Eur. J. Cancer"},{"issue":"12","key":"10.1016\/j.pdpdt.2024.104432_bib0006","article-title":"Interventions for basal cell carcinoma of the skin","author":"Thomson","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.pdpdt.2024.104432_bib0007","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jid.2017.09.033","article-title":"Five-year results of a randomized controlled trial comparing effectiveness of photodynamic therapy, topical imiquimod, and topical 5-fluorouracil in patients with superficial basal cell carcinoma","volume":"138","author":"Jansen","year":"2018","journal-title":"J Invest Dermatol."},{"issue":"12","key":"10.1016\/j.pdpdt.2024.104432_bib0008","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1111\/jdv.16017","article-title":"European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications \u2013 actinic keratoses, Bowen's disease and basal cell carcinomas","volume":"33","author":"Morton","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"10","key":"10.1016\/j.pdpdt.2024.104432_bib0009","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1600-0625.2012.01557.x","article-title":"Protoporphyrin IX formation and photobleaching in different layers of normal human skin: methyl- and hexylaminolevulinate and different light sources","volume":"21","author":"Togsverd-Bo","year":"2012","journal-title":"Exp. Dermatol."},{"issue":"4","key":"10.1016\/j.pdpdt.2024.104432_bib0010","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1365-2133.2006.07484.x","article-title":"Topical application of 5-aminolaevulinic acid, methyl 5-aminolaevulinate and hexyl 5-aminolaevulinate on normal human skin: topical ALA and its esters on human skin","volume":"155","author":"Juzeniene","year":"2006","journal-title":"Br. J. Dermatol."},{"issue":"8","key":"10.1016\/j.pdpdt.2024.104432_bib0011","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1002\/jps.22116","article-title":"Hexyl aminolaevulinate is a more effective topical photosensitiser precursor than methyl aminolaevulinate and 5-aminolaevulinic acids when applied in equimolar doses","volume":"99","author":"Morrow","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.pdpdt.2024.104432_bib0012","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.16441","article-title":"A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy","author":"Morton","year":"2018","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.pdpdt.2024.104432_bib0013","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2340\/00015555-2484","article-title":"Long-term outcome of low-concentration hexyl-5-aminolaevulinate daylight photodynamic therapy for treatment of actinic keratoses","volume":"97","author":"Neittaanm\u00e4ki-Perttu","year":"2017","journal-title":"Acta Derm. Venereol."},{"issue":"12","key":"10.1016\/j.pdpdt.2024.104432_bib0014","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1111\/jdv.16357","article-title":"Hexyl aminolevulinate, 5-aminolevulinic acid nanoemulsion and methyl aminolevulinate in photodynamic therapy of non-aggressive basal cell carcinomas: a non-sponsored, randomized, prospective and double-blinded trial","volume":"34","author":"Salmivuori","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol. JEADV"},{"issue":"5","key":"10.1016\/j.pdpdt.2024.104432_bib0015","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/jdv.12031","article-title":"European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen's disease, basal cell carcinoma","volume":"27","author":"Morton","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol. JEADV"},{"issue":"6","key":"10.1016\/j.pdpdt.2024.104432_bib0016","doi-asserted-by":"crossref","first-page":"531","DOI":"10.4097\/kja.23278","article-title":"Intention-to-treat versus as-treated versus per-protocol approaches to analysis","volume":"76","author":"Ahn","year":"2023","journal-title":"Korean J. Anesthesiol."},{"issue":"2","key":"10.1016\/j.pdpdt.2024.104432_bib0017","doi-asserted-by":"crossref","first-page":"220","DOI":"10.5114\/ada.2023.124795","article-title":"Growth rate of basal cell carcinoma: a meta-analysis and systematic review","volume":"40","author":"Fija\u0142kowska","year":"2023","journal-title":"Adv Dermatol Allergol"},{"issue":"6","key":"10.1016\/j.pdpdt.2024.104432_bib0018","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/bjd.16838","article-title":"Conventional and combination topical photodynamic therapy for basal cell carcinoma: systematic review and meta-analysis","volume":"179","author":"Collier","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.pdpdt.2024.104432_bib0019","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1089361","article-title":"Photodynamic therapy for skin carcinomas: a systematic review and meta-analysis","volume":"10","author":"Ou-Yang","year":"2023","journal-title":"Front Med."},{"issue":"5","key":"10.1016\/j.pdpdt.2024.104432_bib0020","first-page":"547","article-title":"Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial","volume":"18","author":"Basset-Seguin","year":"2008","journal-title":"Eur. J. Dermatol. EJD"},{"issue":"9","key":"10.1016\/j.pdpdt.2024.104432_bib0021","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.143.9.1131","article-title":"Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma","volume":"143","author":"Rhodes","year":"2007","journal-title":"Arch. Dermatol."},{"issue":"7","key":"10.1016\/j.pdpdt.2024.104432_bib0022","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S1470-2045(13)70143-8","article-title":"Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial","volume":"14","author":"Arits","year":"2013","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.pdpdt.2024.104432_bib0023","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/bjd.13924","article-title":"Hexyl-5-aminolaevulinate 0\u00b72% vs. methyl-5-aminolaevulinate 16% daylight photodynamic therapy for treatment of actinic keratoses: results of a randomized double-blinded pilot trial","volume":"174","author":"Neittaanm\u00e4ki-Perttu","year":"2016","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.1016\/j.pdpdt.2024.104432_bib0024","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/bjd.13066","article-title":"Cost-effectiveness of topical imiquimod and fluorouracil vs. photodynamic therapy for treatment of superficial basal-cell carcinoma","volume":"171","author":"Arits","year":"2014","journal-title":"Br. J. Dermatol."},{"issue":"22","key":"10.1016\/j.pdpdt.2024.104432_bib0025","article-title":"Photodynamic therapy for basal cell carcinoma: the clinical context for future research priorities","volume":"25","author":"Collier","year":"2020","journal-title":"Mol. Basel Switz"},{"issue":"6","key":"10.1016\/j.pdpdt.2024.104432_bib0026","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/j.1365-2133.2012.10878.x","article-title":"High and sustained efficacy after two sessions of topical 5-aminolaevulinic acid photodynamic therapy for basal cell carcinoma: a prospective, clinical and histological 10-year follow-up study","volume":"166","author":"Christensen","year":"2012","journal-title":"Br. J. Dermatol. kes\u00e4kuuta"},{"issue":"12","key":"10.1016\/j.pdpdt.2024.104432_bib0027","first-page":"1251","article-title":"Combined CO(2) laser and photodynamic therapy enhances the efficacy of treatment of basal cell carcinomas","volume":"17","author":"Ferrara","year":"2019","journal-title":"J. Dtsch. Dermatol. Ges. J. Ger. Soc. Dermatol. JDDG"},{"issue":"1","key":"10.1016\/j.pdpdt.2024.104432_bib0028","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1111\/bjd.15782","article-title":"Patient preferences for the attributes of a noninvasive treatment for superficial basal cell carcinoma: a discrete choice experiment","volume":"178","author":"Essers","year":"2018","journal-title":"Br. J. Dermatol."}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157210002400468X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157210002400468X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T12:17:43Z","timestamp":1739017063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S157210002400468X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":28,"alternative-id":["S157210002400468X"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2024.104432","relation":{},"ISSN":["1572-1000"],"issn-type":[{"value":"1572-1000","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term outcome of photodynamic therapy with hexyl aminolevulinate, 5-aminolevulinic acid nanoemulsion and methyl aminolevulinate for low-risk Basal Cell Carcinomas","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2024.104432","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104432"}}